top of page

Dr. Daniel Einhorn MD, FACE
Diplomate in Endocrinology and Metabolism
Practice Emeritus

My dear patients,                                                                                                     


I hope this finds you well. As some of you have heard, I am officially leaving the office practice of medicine. As much as I loved being with you for over thirty years, Darius Schneider, MD, PhD and the staff have been doing a great job, and I now feel comfortable leaving the practice in their hands. Please address all your endocrine issues with them and Dr. Schneider has agreed to be the official custodian of the medical records.


My work will now be full time in medical research and education as Vice President for Endocrine Strategy at Corcept Therapeutics, a wonderful company developing medicines that decrease the effect of the stress hormone, cortisol. Being able to do this work is a lifelong dream come true for me, working on therapies that may benefit many people.


I will miss being your doctor, but I will always be happy to hear from you. You taught me so much and I am forever grateful for our friendship.


With warmest wishes,



Education and Training
  • Yale University, BA (Summa Cum Laude, Phi Beta Kappa)

  • Tuft University, MD (Alpha Omega Alpha honors)

  • Graduate medical training at Harvard Medical School, Beth Israel Hospital, Boston MA

  • Fellowship in Endocrinology and Metabolism, Harvard Medical School, Thorndike Labs

Contributions to Science

Over 30 years of clinical research studies have included most of the major innovations in diabetes. These have contributed to the improvement of the life of people with diabetes and their families, and it continues to be a major interest of the group.

Dr. Einhorn was and is part of almost every pharmaceutical and device development in diabetes since the early 1980s. Seeing something as a twinkle in a researcher’s eye, and then seeing it become a product that helps millions of people has been very rewarding. And writing clinical guidelines that change how people practice is also very gratifying.

Dr. Einhorn is Editor of Clinics of North American for Type 2 Diabetes, Editor for Type 2 Diabetes in a Time of Pandemic for The Royal Society of Medicine Press, and an Associate Editor of the Journal of Diabetes. He consults to government, industry, and the media. He is a Fellow of the American College of Physicians and The American College of Endocrinology. He Co-Chaired the national consensus conferences on insulin resistance syndrome and on pre-diabetes. A list of his most recent contributions can be found here.

Professional Memberships
Endocrine Society
American Thyroid Associations
  • Married to Emily for 35 years

  • Daughter Estee, undergraduate at University of Pennsylvania, Urban Studies major

  • Son Max, graduated from Wharton undergrad, working at Oliver Wyman in NYC

  • Loves all music, but especially rock: "I have been part of a rock ‘n’ roll band since I was 12 years old, and my band of the past 15 years is terrific, with wonderful people. We’ve been able to play in places like the Mangy Moose, which is the Carnegie Hall of ski dive bars in Jackson Hole, Wyoming, and other venues where people love the music, dance, get excited and sing. Probably the main thing that moves me is music.

  • Loves theatre and is a trustee of the famed La Jolla Playhouse: "To be around geniuses in the theater is just amazing. To see theater professionals mount productions and create something brilliant from seemingly thin air is really an amazing thing to witness. Outside of my friends and family, those two creative outlets are where I go for inspiration."

bottom of page